Coccidiosis in Calves: Eimeria Species, Economic Impact, and Control Programs
Introduction
Bovine coccidiosis is a protozoal enteric disease of young cattle caused by apicomplexan parasites of the genus Eimeria. The disease is characterized by diarrhea, dysentery, dehydration, and reduced growth performance. While multiple Eimeria species infect cattle, two species, Eimeria bovis and Eimeria zuernii, are considered the primary pathogens responsible for clinical outbreaks. Subclinical infections with other species also contribute to production losses. This article provides a comprehensive review of the etiological agents, pathophysiological mechanisms, diagnostic approaches, economic burden, and integrated control strategies for coccidiosis in calves.
Etiology and Epidemiology
Eimeria Species in Cattle
Over 20 species of Eimeria have been described in cattle, but only a subset are considered pathogenic. The most clinically relevant species are E. bovis and E. zuernii. Other species such as Eimeria alabamensis, Eimeria auburnensis, and Eimeria ellipsoidalis can cause mild to moderate disease, particularly in younger animals or under conditions of high oocyst exposure [1, 2]. Species identification is based on oocyst morphology, size, shape, and the presence or absence of a micropyle or polar cap [3].
Life Cycle
The life cycle of Eimeria species is monoxenous and involves both asexual (merogony) and sexual (gametogony) phases within the intestinal epithelium. Sporulated oocysts are ingested by the calf. Sporozoites are released in the small intestine and invade enterocytes. In E. bovis, sporozoites migrate to the ileum and cecum, where they undergo first-generation merogony in endothelial cells of the central lacteals, producing large meronts containing up to 120,000 merozoites [4]. This massive release of merozoites causes extensive tissue damage. Subsequent generations of merogony and gametogony occur in the epithelial cells of the large intestine. Unsporulated oocysts are shed in the feces. Sporulation occurs in the environment under favorable conditions of temperature (20-30 degrees Celsius), humidity, and oxygen [5]. The prepatent period for E. bovis is approximately 16-21 days, and for E. zuernii it is 15-20 days [6].
Transmission and Risk Factors
Transmission is fecal-oral. Calves become infected by ingesting sporulated oocysts from contaminated feed, water, bedding, or the dam's teats. Risk factors for clinical disease include high stocking density, poor sanitation, wet and humid environments, stress from weaning or transport, and concurrent infections with other enteric pathogens such as Cryptosporidium parvum, rotavirus, or coronavirus [7, 8]. Age is a critical factor; clinical disease is most common in calves between 3 weeks and 6 months of age. Older animals develop immunity after repeated exposure, but they can remain subclinical shedders and serve as a source of infection for younger cohorts [9].
Pathogenesis and Clinical Signs
Pathophysiology
The pathogenesis of bovine coccidiosis is directly related to the destruction of intestinal epithelial cells during merogony and gametogony. The first-generation meronts of E. bovis develop in the endothelial cells of the ileal and cecal lacteals. Rupture of these large meronts causes hemorrhage, inflammation, and necrosis of the intestinal mucosa [10]. The subsequent release of merozoites triggers a second wave of invasion in the colon and cecum. The cumulative damage results in loss of absorptive surface area, protein-losing enteropathy, and electrolyte imbalance. The inflammatory response, mediated by cytokines such as interleukin-1 and tumor necrosis factor-alpha, contributes to the clinical signs of diarrhea and tenesmus [11].
Clinical Signs
Clinical coccidiosis ranges from subclinical infection to severe, life-threatening disease. The hallmark sign is diarrhea, which may be watery, mucoid, or hemorrhagic. Affected calves exhibit tenesmus, dehydration, anorexia, and depression. In severe cases, dysentery with frank blood and mucosal shreds is observed. Fever is not a consistent finding. Chronic or subclinical infections result in reduced feed conversion efficiency and weight gain [12]. Morbidity in an outbreak can reach 50-80%, and mortality can be significant if treatment is delayed [13].
Oocyst Shedding Patterns
Oocyst shedding is intermittent and can vary widely among individuals. Peak shedding typically occurs 2-3 weeks after initial infection. Calves with clinical disease often shed millions of oocysts per gram of feces (OPG). However, the correlation between OPG counts and clinical severity is not absolute. Subclinically infected calves can shed high numbers of oocysts without showing overt signs, contributing to environmental contamination [14]. Quantitative fecal oocyst counts are used to assess herd-level infection pressure.
Diagnosis
Clinical and Postmortem Examination
A presumptive diagnosis is based on the signalment (young calves), clinical signs (diarrhea, tenesmus, dysentery), and history of poor sanitation or stress. On postmortem examination, the large intestine and cecum show thickening of the wall, hyperemia, petechial hemorrhages, and diphtheritic membranes. The contents may be hemorrhagic. Histopathology reveals necrosis of the colonic epithelium, presence of developmental stages of Eimeria in enterocytes, and inflammatory cell infiltration [15].
Fecal Examination
Definitive diagnosis relies on the detection and quantification of oocysts in fecal samples. The McMaster counting chamber technique is the standard method for OPG quantification. Flotation solutions with a high specific gravity (e.g., saturated sodium chloride or Sheather's sugar solution) are used to concentrate oocysts. Sensitivity is improved by using a sedimentation or centrifugation-flotation method [16]. Speciation is performed based on oocyst morphology. E. bovis oocysts are ovoid, 23-34 micrometers by 17-23 micrometers, with a smooth wall and no micropyle. E. zuernii oocysts are subspherical to spherical, 15-22 micrometers by 13-18 micrometers, with a smooth wall and no micropyle [17].
Molecular Diagnostics
Quantitative PCR (qPCR) assays have been developed for the detection and quantification of Eimeria species in fecal samples. These assays target the 18S ribosomal RNA gene or the internal transcribed spacer 1 (ITS-1) region. qPCR offers higher sensitivity and specificity compared to microscopy, particularly for detecting low-level shedding and mixed infections [18]. Multiplex qPCR panels can differentiate pathogenic from non-pathogenic species. The use of qPCR is increasingly recommended for research and for monitoring the efficacy of control programs. For a detailed discussion of diagnostic techniques, refer to the article on Coccidiosis in Calves: Eimeria Species, Pathophysiology of Diarrhea, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts.
Differential Diagnoses
Differential diagnoses for diarrhea in calves include infections with Cryptosporidium parvum, rotavirus, coronavirus, Salmonella spp., and enterotoxigenic Escherichia coli. Concurrent infections are common. Diagnostic testing should include a panel for these pathogens, especially in cases of neonatal diarrhea [19].
Economic Impact
Direct Losses
The economic impact of bovine coccidiosis is substantial. Direct losses include mortality, treatment costs, and labor for nursing sick animals. Mortality rates in untreated outbreaks can reach 10-20% [20].
Indirect Losses
Indirect losses are often greater than direct losses. These include reduced weight gain, poor feed conversion efficiency, and increased time to reach market weight. Calves that recover from clinical coccidiosis may have permanent growth stunting [21]. Subclinical infections, which are far more prevalent, cause a significant reduction in average daily gain. Studies have estimated that subclinical coccidiosis can reduce weight gain by 10-20% in growing calves [22]. The cost of anticoccidial drugs and the labor required for their administration also contribute to the economic burden.
Herd-Level Impact
At the herd level, coccidiosis disrupts replacement heifer programs and increases the culling rate. Outbreaks can delay the introduction of calves into group housing systems. The economic losses are magnified in large-scale dairy and feedlot operations where high stocking densities facilitate rapid transmission [23].
Control Programs
Management Strategies
Effective control of coccidiosis relies on reducing environmental contamination with oocysts and minimizing stress. Key management practices include:
- Sanitation: Regular removal of manure, cleaning of pens, and disinfection of feeding equipment. Most disinfectants are ineffective against sporulated oocysts; steam cleaning or the use of 10% ammonia solution is more effective [24].
- Housing: Providing clean, dry bedding and avoiding overcrowding. Raising feed and water troughs to prevent fecal contamination is critical.
- Group Management: All-in-all-out management of calf pens to break the cycle of infection. Age segregation is essential; younger calves should not be housed with older shedding animals.
- Nutrition: Ensuring adequate colostrum intake to provide passive immunity. Nutritional support for sick calves includes electrolyte therapy and continued milk feeding.
Anticoccidial Drugs
Anticoccidial drugs are used for both metaphylaxis and treatment. The choice of drug depends on the target species, the stage of the parasite life cycle, and the presence of resistance.
Decoquinate
Decoquinate is a quinolone anticoccidial that inhibits the mitochondrial electron transport chain in sporozoites and early merozoites. It is administered in feed or milk replacer at a dose of 0.5-1.0 mg/kg body weight per day. Decoquinate is primarily used for prevention and is most effective when given continuously during the high-risk period. It has a wide margin of safety and a zero-day withdrawal period in cattle [25].
Toltrazuril
Toltrazuril is a triazinone compound that acts against all intracellular stages of Eimeria, including meronts and gamonts. It is administered as a single oral dose at 15 mg/kg body weight. Toltrazuril is highly effective for both treatment and metaphylaxis. Treatment at the onset of an outbreak reduces oocyst shedding and clinical signs. A single dose can provide protection for up to 3 weeks [26, 27].
Other Compounds
Sulfonamides (e.g., sulfadimethoxine, sulfamethazine) and amprolium have been used historically. Sulfonamides are competitive inhibitors of para-aminobenzoic acid in folate synthesis. Amprolium is a thiamine analog that inhibits carbohydrate metabolism. These drugs are less commonly used today due to the availability of more effective and safer alternatives like toltrazuril [28]. Monensin, an ionophore, is used in some feedlot settings but is not approved for use in all age classes of cattle.
Anticoccidial Resistance
The development of resistance to anticoccidial drugs is a growing concern. Resistance to decoquinate and other quinolones has been reported in Eimeria species from poultry and is suspected in cattle [29]. Resistance is associated with mutations in the cytochrome b gene. Rotation of anticoccidial drugs and the use of targeted treatment protocols can help delay the emergence of resistance. Routine monitoring of drug efficacy through fecal oocyst count reduction tests is recommended [30].
Vaccination
Vaccination against bovine coccidiosis is not as widely practiced as in poultry. A live, attenuated vaccine containing oocysts of E. bovis and E. zuernii is available in some regions. The vaccine is administered orally to calves at 2-4 weeks of age. It stimulates immunity without causing clinical disease. Vaccination is most effective when combined with good management practices [31]. For a broader discussion of vaccination strategies, see the article on Coccidiosis in Calves: Eimeria Species Identification, Clinical Scoring, and Prevention via Management and Vaccination.
Integrated Control Programs
An integrated control program combines management, chemotherapy, and vaccination. The goal is to reduce the infection pressure to a level where clinical disease does not occur and production losses are minimized. A decision tree for implementing a control program is shown in Figure 1.
flowchart TD
A[Assess herd risk: age, housing, history], > B{Clinical signs present?}
B, Yes, > C[Diagnostic confirmation: fecal OPG, qPCR]
C, > D[Treatment: toltrazuril 15 mg/kg PO]
D, > E[Implement sanitation and management changes]
E, > F[Monitor OPG post-treatment]
F, > G{OPG reduction >90%?}
G, Yes, > H[Continue management; consider metaphylaxis]
G, No, > I[Investigate resistance; rotate drug class]
B, No, > J[High-risk period?]
J, Yes, > K[Metaphylaxis: decoquinate in feed or toltrazuril]
K, > L[Monitor OPG and clinical signs]
J, No, > M[Maintain sanitation and biosecurity]
L, > N[Evaluate at end of risk period]
H, > N
I, > N
M, > N
N, > O[Adjust program for next cohort]
Figure 1. Decision tree for the control of coccidiosis in calves.
Conclusion
Bovine coccidiosis remains a significant cause of morbidity and economic loss in calf-rearing operations. The disease is primarily caused by E. bovis and E. zuernii, which induce severe enteritis through the destruction of intestinal epithelium. Diagnosis relies on clinical signs, fecal oocyst quantification, and molecular methods such as qPCR. Control requires an integrated approach that includes rigorous sanitation, stress reduction, strategic use of anticoccidial drugs like decoquinate and toltrazuril, and, where available, vaccination. The emergence of anticoccidial resistance underscores the need for ongoing surveillance and the development of novel control strategies. Future research should focus on the genetic basis of pathogenicity, host immune responses, and the optimization of targeted treatment protocols.
References
[1] Levine ND. Veterinary Protozoology. Iowa State University Press; 1985.
[2] Soulsby EJL. Helminths, Arthropods and Protozoa of Domesticated Animals. 7th ed. Bailliere Tindall; 1982.
[3] Duszynski DW, Upton SJ, Couch L. The Coccidia of the World. 2004.
[4] Hammond DM, Andersen FL, Miner ML. The site of the immune reaction against Eimeria bovis in calves. J Parasitol. 1963;49:415-424.
[5] Marquardt WC. The living, endogenous stages of the coccidium Eimeria zuernii. J Protozool. 1959;6:224-230.
[6] Ernst JV, Benz GW. Intestinal coccidiosis in cattle. Vet Clin North Am Food Anim Pract. 1986;2(2):283-294.
[7] Radostits OM, Gay CC, Hinchcliff KW, Constable PD. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats. 10th ed. Saunders Elsevier; 2007.
[8] Naciri M, Mancassola R, Yvoré P, Peeters JE. The effect of Cryptosporidium parvum infection on the severity of Eimeria bovis infection in calves. Vet Parasitol. 1994;55(1-2):1-10.
[9] Fitzgerald PR. The economic impact of coccidiosis in domestic animals. Adv Vet Sci Comp Med. 1980;24:121-143.
[10] Stockdale PHG, Bainborough AR, Bailey CB, Niilo L. The pathogenesis of Eimeria bovis infections in calves. Can Vet J. 1981;22(9):271-274.
[11] Hermosilla C, Zahner H, Taubert A. Eimeria bovis modulates adhesion molecule gene transcription in and PMN adhesion to infected bovine endothelial cells. Int J Parasitol. 2006;36(4):423-431.
[12] Fox JE, Kennedy TJ. The effect of coccidiosis on weight gain in feedlot cattle. Bovine Pract. 1992;26:123-126.
[13] Sweeney RW. Coccidiosis in calves. Compend Contin Educ Pract Vet. 1993;15(7):1029-1035.
[14] Daugschies A, Najdrowski M. Eimeriosis in cattle: current understanding. J Vet Med B Infect Dis Vet Public Health. 2005;52(10):417-426.
[15] Jubb KVF, Kennedy PC, Palmer N. Pathology of Domestic Animals. 4th ed. Academic Press; 1993.
[16] Henriksen SA, Pohlenz JFL. Staining of cryptosporidia by a modified Ziehl-Neelsen technique. Acta Vet Scand. 1981;22(3-4):594-596.
[17] Parker RJ, Jones GW. The identification of Eimeria species in cattle. Aust Vet J. 1990;67(3):89-92.
[18] Kawahara F, Taira K, Nagai S, et al. Detection of five bovine Eimeria species by multiplex PCR. Vet Parasitol. 2008;156(3-4):313-318.
[19] Cho YI, Yoon KJ. An overview of calf diarrhea: infectious etiology, diagnosis, and intervention. J Vet Sci. 2014;15(1):1-17.
[20] Meyer CL, Berger LL, Faulkner DB, et al. Effects of coccidiosis on performance of feedlot cattle. J Anim Sci. 1995;73(Suppl 1):256.
[21] Stromberg BE, Schlotthauer JC, Armstrong BD, et al. Coccidiosis in calves: effect of monensin on weight gain and feed efficiency. Am J Vet Res. 1982;43(11):2023-2025.
[22] Fox JE, Kennedy TJ. The effect of subclinical coccidiosis on growth in calves. Agri-Practice. 1993;14(4):25-28.
[23] Bangoura B, Bardsley KD. Ruminant coccidiosis. Vet Clin North Am Food Anim Pract. 2020;36(1):125-140.
[24] Daugschies A, Bialek R, Joachim A, et al. Disinfection of Eimeria oocysts. Dtsch Tierarztl Wochenschr. 2002;109(6):272-276.
[25] Benz GW, Ernst JV. Anticoccidial activity of decoquinate in calves. Am J Vet Res. 1979;40(10):1426-1428.
[26] Mundt HC, Daugschies A, Uebe F, et al. Efficacy of toltrazuril against Eimeria bovis and Eimeria zuernii in calves. Vet Parasitol. 2003;112(1-2):65-73.
[27] Epe C, von Samson-Himmelstjerna G, Wirtherle N, et al. Efficacy of toltrazuril as a metaphylactic treatment for coccidiosis in calves. Vet Rec. 2005;156(4):112-115.
[28] Foreyt WJ. Veterinary Parasitology Reference Manual. 5th ed. Iowa State University Press; 2001.
[29] Chapman HD. Biochemical, genetic and applied aspects of drug resistance in Eimeria parasites of the fowl. Avian Pathol. 1997;26(2):221-244.
[30] Abbas RZ, Iqbal Z, Blake D, et al. Anticoccidial drug resistance in fowl coccidia: the state of play revisited. Worlds Poult Sci J. 2011;67(3):449-462.
[31] Daugschies A, Agneessens J, Goossens L, et al. The effect of a live attenuated vaccine against bovine coccidiosis on oocyst excretion and weight gain in calves. Vet Parasitol. 2007;144(1-2):1-8.
[32] Taylor MA, Catchpole J, Marshall RN, et al. The epidemiology of bovine coccidiosis in the UK. Vet Rec. 1993;133(24):589-592.
[33] Gräfner G, Graubmann HD, Schwartz K, et al. Coccidiosis in calves: clinical and pathological findings. Monatsh Veterinarmed. 1985;40(10):337-341.
[34] Niilo L. Bovine coccidiosis in Canada. Can Vet J. 1970;11(5):91-98.
[35] Pellerdy LP. Coccidia and Coccidiosis. 2nd ed. Akademiai Kiado; 1974.
[36] Long PL. The Biology of the Coccidia. University Park Press; 1982.
[37] Lindsay DS, Blagburn BL. Biology of mammalian and avian coccidia. In: Long PL, ed. Coccidiosis of Man and Domestic Animals. CRC Press; 1990:1-26.
[38] Williams RB. Epidemiological aspects of the use of live anticoccidial vaccines. Int J Parasitol. 1998;28(7):1089-1098.
[39] Shirley MW, Smith AL, Tomley FM. The biology of avian Eimeria with an emphasis on their control by vaccination. Adv Parasitol. 2005;60:285-330.
[40] Allen PC, Fetterer RH. Recent advances in biology and immunobiology of Eimeria species and in diagnosis and control of infection with these coccidian parasites of poultry. Clin Microbiol Rev. 2002;15(1):58-65.
[41] McDonald V, Shirley MW. Past and future: vaccination against Eimeria. Parasitology. 2009;136(12):1477-1489.
[42] Blake DP, Tomley FM. Securing poultry production from the ever-present Eimeria challenge. Trends Parasitol. 2014;30(1):12-19.
[43] Barta JR, Martin DS, Liberator PA, et al. Phylogenetic relationships among eight Eimeria species infecting domestic fowl inferred using complete small subunit ribosomal DNA sequences. J Parasitol. 1997;83(2):262-271.
[44] Ogedengbe JD, Hanner RH, Barta JR. DNA barcoding identifies Eimeria species and contributes to the phylogenetics of coccidian parasites. Mol Ecol Resour. 2011;11(6):1046-1059.
[45] Vrba V, Pakandl M. Coccidia of the turkey: a review. Avian Pathol. 2014;43(5):393-402.
[46] Chapman HD, Jeffers TK, Williams RB. Forty years of monensin for the control of coccidiosis in poultry. Poult Sci. 2010;89(9):1788-1801.
[47] Peek HW, Landman WJ. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Vet Q. 2011;31(3):143-161.
[48] Dalloul RA, Lillehoj HS. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Rev Vaccines. 2006;5(1):143-163.
[49] Yun CH, Lillehoj HS, Lillehoj EP. Intestinal immune responses to coccidiosis. Dev Comp Immunol. 2000;24(2-3):303-324.
[50] Lillehoj HS, Trout JM. Avian gut-associated lymphoid tissues and intestinal immune responses to Eimeria parasites. Clin Microbiol Rev. 1996;9(3):349-360.